Dr Reddys to launch anti-COVID drug Molnupiravir under brand name Molflu at Rs 35 per capsule Medical Dialogues Bureau5 Jan 2022 3:53 PM IST"Molflu (Molnupiravir) is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high...
IPC flags adverse reaction linked to popular COVID drug Remdesivir Medical Dialogues Team4 Jan 2022 6:55 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of December, has revealed that...
Takeda Pharma gets CDSCO panel nod to market Vadolizumab for subcutaneous route Medical Dialogues Team2 Jan 2022 11:30 AM ISTNew Delhi: Takeda Pharmaceuticals has got the go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 7:36 PM ISTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
NPPA fixes ceiling price of water for injection, Details Medical Dialogues Team31 Dec 2021 5:33 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of water for injection in 500 ml...
Mankind Pharma Launches Anti-COVID-19 pill Molulife- Molnupiravir 200mg Ruchika Sharma30 Dec 2021 1:03 PM ISTTaking a significant step towards countering COVID-19 in India, drug major Mankind Pharma has announced the launch of the oral anti- COVID...
NPPA still to recover Rs 8098.78 crore from pharma firms for overcharging Medical Dialogues Team29 Dec 2021 6:41 PM ISTNew Delhi: The total outstanding amount pending to be paid by the pharmaceutical companies for alleged overcharging stands at Rs 8,098.78 crore, the...
Cipla bags DCGI nod for COVID-19 oral antiviral, all set to launch Cipmolnu in India Ruchika Sharma28 Dec 2021 3:00 PM ISTMolnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.
AstraZeneca to study cancer drug Datopotamab deruxtecan in India Medical Dialogues Team27 Dec 2021 6:39 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
Cipla gets CDSCO panel nod to market antineoplastic drug Hydroxyurea Medical Dialogues Team26 Dec 2021 11:15 AM ISTNew Delhi: In a significant development, drug-major Cipla has got a go ahead from from the Subject Expert Committee (SEC) functional under the Central...
Ibuprofen makers to add adverse reaction Stevenson Johnson Syndrome in package insert: CDSCO panel Medical Dialogues Team25 Dec 2021 5:04 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Finally Molnupiravir gets USFDA nod Ruchika Sharma24 Dec 2021 11:36 AM ISTKenilworth: A day after Pfizer's Paxlovid bagged the U.S. Food and Drug Administration (USFDA) Emergency Use Authorization (EUA) nod, Merck's...
